Mast cells contribute to vasculogenic mimicry in multiple myeloma.
The angiogenic response is amplified during the induction phase of multiple myeloma (MM) and appears to exert a key role in the development of the disease [1]. Thus, inhibitors of angiogenesis have proven therapeutic potential in the treatment of patients with MM. Angiogenesis induced during the development of MM involves the direct production of proangiogenic cytokines by plasma cells within the marrow microenvironment. Mast cells (MCs) contribute to the the composition of the cellular components of the microenvironment in patients with MM, but their role in the pathophysiology of the disease is not clear. In this report, we used electron and confocal microscopy approaches to investigate the participation of MCs in the formation of the vessel wall in biopsy specimens from patients with MM. Results were compared to those obtained from the biopsy material of patients with a benign lesion, namely monoclonal gammopathy of undetermined significance (MGUS). Our results show that patients with MM exhibit typical tryptase-positive MCs, which interact physically with the endothelial cells (ECs) lining the vascular lumina, perhaps as a result of dysregulated vasculogenic development. This evidence highlights the importance of the stromal microenvironment during angiogenesis in the pathophysiology of MM and provides a novel perspective into the complex interplay between stromal and vascular components in the bone marrow microenvironment involved in the induction of hyervascularization in MM.
Nico
Beatrice
B
Department of Human Anatomy and Histology, University of Bari Medical School, Bari, Italy.
Mangieri
Domenica
D
Crivellato
Enrico
E
Vacca
Angelo
A
Ribatti
Domenico
D
D001808:Blood Vessels / Q000473:pathology; D001853:Bone Marrow; D002450:Cell Communication; D042783:Endothelial Cells / Q000473:pathology; D004730:Endothelium, Vascular; D006801:Humans; D008407:Mast Cells / Q000473:pathology*; D008854:Microscopy, Electron; D009101:Multiple Myeloma / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000473:pathology*